Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phenylmercuric borate is an organomercuric compound used as a topical antiseptic and disinfectant. It was widely employed until the 1990s for wound treatment of the skin, mouth, and throat, as well as in disinfectants under brand names such as Merfen Orange. Its antimicrobial action is both bactericidal (against many Gram-positive and Gram-negative species) and fungicidal (notably against Candida albicans and Aspergillus niger). The mechanism involves rapid incorporation into microbial cells—particularly associating with ribosomal proteins—disrupting cellular function. Due to its high mercury content and associated toxicity risks (including increased systemic absorption through skin contact), it has largely been replaced by safer alternatives[1][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phenylmercuric borate.